NCT01999686 - PCOS Treatment Using DLBS3233, Metformin, and Combination of Both | Biotech Hunter

Enrollment

186

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 28, 2019

Study Completion Date

May 31, 2019

Conditions

Polycystic Ovary Syndrome (PCOS)Insulin Resistance

Interventions

DRUG

DLBS3233

DRUG

Metformin XR

DRUG

Placebo metformin

Placebo metformin has the same ingredients with Metformin XR caplet, except that it does not contain the active substance (metformin).

DRUG

Placebo DLBS3233

Placebo DLBS3233 has the same ingredients with DLBS3233 capsule, except that it does not contain the active substance (DLBS3233).

Trial Locations (7)

Unknown

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lambung Mangkurat, Ulin Banjarmasin Hospital, Banjarmasin

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Udayana, Sanglah Hospital, Denpasar

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Hasanuddin, Dr. Wahidin Sudirohusodo Hospital, Makasar

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Brawijaya, Dr. Saiful Anwar Hospital, Malang

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Sam Ratulangi, Prof. Dr. Kandou Hospital, Manado

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, Diponegoro University, Dr. Kariadi Hospital, Semarang

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Airlangga, Dr. Soetomo Hospital., Surabaya